WMT
75
13
BLK
58
-3
PH
67
-4
DOV
79
-4
GWW
55
-9
CHK
20
-19
KLAC
67
-4
BIIB
48
-3
TGT
61
4
SWK
62
-2
EQIX
57
-2
FRT
51
-7
CLX
50
4
VZ
32
-3
SHW
62
-2
CPB
49
2
PHM
70
-4
CRM
55
-2
HAS
43
-3
DO
83
2
WMT
75
13
BLK
58
-3
PH
67
-4
DOV
79
-4
GWW
55
-9
CHK
20
-19
KLAC
67
-4
BIIB
48
-3
TGT
61
4
SWK
62
-2
EQIX
57
-2
FRT
51
-7
CLX
50
4
VZ
32
-3
SHW
62
-2
CPB
49
2
PHM
70
-4
CRM
55
-2
HAS
43
-3
DO
83
2
Financhill
Back

AXIM Biotechnologies 10K Form

Sell
37

AXIM
AXIM Biotechnologies

Last Price:
0.0100
Seasonality Move:
39.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXIM News And Ratings

See the #1 stock for the next 7 days that we like better than AXIM

AXIM Financial Statistics

Sales & Book Value

Annual Sales: $39.52K
Cash Flow: $19.6K
Price / Cash Flow: 0
Annual Sales: $-0.03
Price / Book: 0

Profitability

EPS (TTM): -0.04230
Net Income (TTM): $-8.06M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: -194.99%

AXIM Biotechnologies Earnings Forecast

Key AXIM Biotechnologies Financial Ratios

  • The Selling, General & Administrative Expenses for AXIM have been equal to 5,662.55% of Gross Profit Margin.
  • The Research & Development expenses have been 317.56% of Revenue.
  • The Interest Expense is -14.95% of Operating Income.
  • The Net Earning history of AXIM is -20,393.93% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

AXIM Biotechnologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: AXIM
Website: aximbiotech.com

Debt

Debt-to-Equity Ratio: -0.74
Current Ratio: 0.03
Quick Ratio: 0.03

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AXIM Technical Analysis vs Fundamental Analysis

Sell
37
AXIM Biotechnologies (AXIM) is a Sell

Is AXIM Biotechnologies a Buy or a Sell?